Terpenoid Therapeutics was recently mentioned in this Nature Biotechnology article:
By Cormac Sheridan
Can the commercial sector capitalize on the merger of high-throughput technology and natural products? Cormac Sheridan investigates.
The recent fanfare surrounding Warp Drive Bio, a startup with an ambitious agenda to marry natural products–based drug discovery with modern genomics, signals that there may still be life in what has become a moribund niche of the pharmaceutical industry. Although natural products research has historically been a mainstay of drug developers—
in previous eras, around half of all drugs had their origins in natural sources—interest in the area has dwindled in recent decades.